tes the dynamic shifts that are occurring in the distribution of medical information."
"The opportunity to widely share important findings that promptly impact practice is becoming a powerful tool to drive change," Yancy said. "The requirements for prompt but thorough peer review and nimble responsiveness to new data are evident. Managing this new health IT space will require focus, assessment and realignment."
More information
The Society for Vascular Surgery has more about angioplasty and stenting.
-- Robert Preidt
SOURCE: American Heart Association, news release, July 28, 2009
'/>"/>Copyright©2009 ScoutNews,LLC. All rights reserved | |
Page: 1 2 Related medicine news :1.
QHR Client Hospitals Lauded for Consistently High Quality Standards, Exceeding Patient Expectations2.
FDA Approves Boston Scientifics TAXUS(R) Liberte(R) Long Stent3.
AbbeyMoor Medical Receives FDA Approval for Design Improvements to The Spanner(TM) Prostatic Stent4.
CorNova(R) Receives CE Mark Approval for Valecor Platinum(R) Coronary Stent System5.
Abbott Receives CE Mark for Companys Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Advancing Leadership Position6.
Newest Coated Stent Does Well in Real-World Trial7.
AMA Supports Health System Reform Alternatives Consistent With Principles of Pluralism, Freedom of Choice, Freedom of Practice and Universal Access for Patients8.
Analysis of drug-eluting stents data demonstrates safety, efficacy in on-and-off-label use9.
InstaMed Achieves CAQH CORE Rules Certification, Streamlines Provider Access to Consistent Electronic Eligibility, Benefits and Patient Financial Liability Data10.
Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Building Upon Superior Outcomes from SPIRIT Family of Trials11.
Broncus Technologies Exhale Stent and Other New Devices to Prompt Robust Growth In Emphysema Treatment Market, According to Millennium Research Group